Skip to Content »

Site Map

FREE Shipping: All Individuals in United States, Mexico, Central and South America & The Caribbean

Antibacterial Therapy and Newer Agents , An Issue of Medical Clinics of North America

Please note that due to a system merger our fulfilment system will be down beginning September 22nd with an anticipated date to begin shipping orders October 10th. We would like to apologize for any inconvenience by offering you a special 20% discount on select products. Please use Promotional Code 12760. Click here for promotion details.

$83.00

In Stock

This issue of Medical Clinics of North America brings the physician up to date on the newest agents for antibacterial therapy.  New drugs are covered, as well as new approaches.  Topics include the newer fluoroquinolones; epidemiology, molecular mechanisms, and clinical management of pathogens resistant to antibacterial agents; current use for old antibacterial agents, including polymyxins, rifamycins, and aminoglycosides; topical antibacterial agents; newer beta-lactam antibiotics, including doripenem, ceftobiprole. ceftaroline, and cefepim; the use of antibacterial agents in renal failure; antibiotics for gram positive bacterial infections, including vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinolones, daptomycin, telavancin, and ceftaroline; as well as macrolides, ketolides, and glycylcyclines, including azithromycin, clarithromycin, telithromycin, and tigecycline.

View other titles in the “ The Clinics: Internal Medicine” Series

View all Internal Medicine titles

Author Information

    By Keith Kaye, MD, Detroit Medical Center and Wayne State University, Detroit, MI and Donald Kaye, MD, MACP

Customer Reviews

Antibacterial Therapy and Newer Agents , An Issue of Medical Clinics of North America
  • Hardcover
  • Reference
  • 224 Pages
  • Imprint: Saunders
  • ISBN: 978-1-4557-2291-4
  • Copyright: 2011